An altered immune response to Epstein-Barr virus in multiple sclerosis -: A prospective study

被引:214
|
作者
Sundström, P
Juto, P
Wadell, G
Hallmans, G
Svenningsson, A
Nyström, L
Dillner, J
Forsgren, L
机构
[1] Univ Umea Hosp, Dept Neurol, Umea, Sweden
[2] Univ Umea Hosp, Dept Virol, Umea, Sweden
[3] Umea Univ, Dept Publ Hlth & Clin Med, S-90187 Umea, Sweden
[4] Lund Univ, Malmo Univ Hosp, Dept Med Microbiol, S-22100 Lund, Sweden
关键词
D O I
10.1212/01.WNL.0000130496.51156.D7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To investigate the association between human herpesviruses and multiple sclerosis ( MS), as well as between measles virus and MS. Methods: The authors identified prospectively collected serum samples from 73 MS cases and retrospective sera from 161 MS cases in two population-based serum bank registers. Analyses of IgG antibody responses in cases and matched referents were performed for Epstein-Barr virus (EBV [EBNA-1 and VCA]), human herpesvirus 6 (HHV-6), herpes simplex virus (HSV), varicella zoster virus (VZV), and measles. Results: All cases showed signs of past EBV infection. High activity to EBNA-1 and HHV-6 significantly ( borderline significance for HHV-6) increased the risk for MS in prospective sera. A discrepancy between activities to EBNA-1 and VCA was striking in MS samples collected less than 5 years before relapsing-remitting MS onset, where high activity to EBNA-1 significantly increased, and high VCA activity significantly decreased the risk for MS. There was no support for major causal roles for HSV, VZV, or measles. Conclusion: Individuals who will develop MS exhibit an altered immune response against the EBV virus characterized by a high IgG activity to EBNA-1 in the absence of high activity to VCA, this being most pronounced in the 5-year period preceding MS onset.
引用
收藏
页码:2277 / 2282
页数:6
相关论文
共 50 条
  • [41] Variability of Epstein-Barr Virus Activity and the Anti-EBV Immune Response in Multiple Sclerosis
    Lindsey, John
    Latham, Leigh
    NEUROLOGY, 2013, 80
  • [42] Serologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple Sclerosis
    Cortese, Marianna
    Leng, Yumei
    Bjornevik, Kjetil
    Mitchell, Moriah
    Healy, Brian C.
    Mina, Michael J.
    Mancuso, James D.
    Niebuhr, David W.
    Munger, Kassandra L.
    Elledge, Stephen J.
    Ascherio, Alberto
    JAMA NEUROLOGY, 2024, 81 (05) : 515 - 524
  • [43] Antibody response to individual Epstein-Barr virus proteins in multiple sclerosis
    Lindsey, J.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 163 - 163
  • [44] EPSTEIN-BARR VIRUS AND THE IMMUNE-RESPONSE
    THOMPSON, PJ
    LANCET, 1983, 1 (8314): : 70 - 70
  • [45] Multiple Sclerosis and Epstein-Barr Virus: A Current Review
    Ruprecht, K.
    AKTUELLE NEUROLOGIE, 2013, 40 (07) : 400 - 407
  • [46] Epstein-Barr virus is not present in multiple sclerosis brain
    Sargsyan, Siranush A.
    Shearer, Andrew J.
    Ritchie, Alanna M.
    Burgoon, Mark P.
    Anderson, Sarah W.
    Corboy, John
    Owens, Gregory P.
    Gilden, Donald H.
    Bennett, Jeffrey L.
    JOURNAL OF NEUROVIROLOGY, 2009, 15 : 85 - 85
  • [47] Epstein-Barr virus and multiple sclerosis: supporting causality
    Aloisi, Francesca
    Salvetti, Marco
    LANCET NEUROLOGY, 2022, 21 (04): : 300 - 301
  • [48] A role for the Epstein-Barr virus in multiple sclerosis aetiology?
    Hrastelj, J.
    Robertson, N. P.
    JOURNAL OF NEUROLOGY, 2022, 269 (07) : 3962 - 3963
  • [49] Epstein-Barr virus and multiple sclerosis: causation or association?
    Kakalacheva, Kristina
    Comabella, Manuel
    FUTURE MICROBIOLOGY, 2010, 5 (11) : 1617 - 1619
  • [50] Epstein-Barr virus and risk of multiple sclerosis - Reply
    Levin, L
    Munger, K
    Ascherio, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02): : 193 - 193